News
-
-
-
-
PRESS RELEASE
EQS-Adhoc: BRAIN Biotech AG Appoints Dr. Sven K. Weber as New Chairman of the Executive Board, Effective October 1, 2026
BRAIN Biotech AG appoints Dr. Sven K. Weber as new Chairman of the Executive Board, effective October 1, 2026. Dr. Weber, with experience at BASF SE, replaces Adriaan Moelker -
-
-
-
PRESS RELEASE
BRAIN Biotech AG reports half-year figures for fiscal year 2025/26 and confirms full year guidance
BRAIN Biotech AG reports half-year figures for fiscal year 2025/26, with sequential growth in core segment BRAINBiocatalysts and a new European patent for genome editing. Full year guidance confirmed -
-